Submit your Cellcept claim details for a free, no obligation case review
Get Started:
A number of Cellcept deaths have been reported to the U.S. Food and Drug Administration (FDA). The Early Communication issued by the FDA in April 2008 notes the possible connection between CellCept and deaths due to PML, or progressive multifocal leukoencephalopathy, a life-threatening neurological disease. The prognosis for a patient who has developed PML after CellCept treatment is very poor, and there is no sure cure available for PML.
A patient who has been treated with CellCept should be aware of the symptoms of PML:
If you’ve been treated with CellCept and experiencing any of these symptoms, seek medical attention immediately.
In addition to the CellCept deaths related to PML, a significant number of miscarriages are confirmed to have been caused by CellCept. The warnings on CellCept packaging now include wording advising that any female patient of childbearing age be on contraception (preferably, two methods of contraception) before, during, and for weeks following CellCept treatment. The death of one’s unborn child can be a very traumatic event, and CellCept treatment should not be the cause of a baby’s death.
Talk to an attorney who helps the victims of dangerous drugs such as CellCept. If you’ve suffered losses due to a CellCept death or injury, you may be eligible for financial compensation from the maker of CellCept, Roche Holding AG.
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice